GENSCRIPT BIO

Forecast & Rating8 analysts currently cover GENSCRIPT BIO, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$17.76, about 5.6% upside from the current price of HK$16.82. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 23.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study GENSCRIPT BIO closely still see room for the stock to rise. Data as of Jul 23, 2026; for reference only and not investment advice.